By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Today’s Political Science Science Briefing | March 25th 2026, 1:00:12 pm

Today’s Neurology Science Briefing | March 25th 2026, 1:00:12 pm

Today’s Renewable Energy Science Briefing | March 25th 2026, 1:00:12 pm

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Today’s Diabetes Science Briefing | March 24th 2026, 1:00:12 pm

Medicine

Today’s Diabetes Science Briefing | March 24th 2026, 1:00:12 pm

Last updated: March 24, 2026 12:01 pm
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
A real-world study in China found that lecanemab, a new Alzheimer’s drug, significantly slowed cognitive decline in patients over six months. This suggests the treatment is effective outside of controlled clinical trials and may offer hope for slowing the progression of the disease.
Source →

•
The study also identified a blood test for a protein called p‑tau217 as a potential way to monitor how well a patient is responding to lecanemab treatment. This could provide a simpler and less invasive alternative to brain scans for tracking the drug’s effect on the brain.
Source →

•
A study on pregnant and postpartum women with severe lung failure (ARDS) found that nearly half (49.2%) of the mothers died. This highlights the extreme danger this condition poses during and after pregnancy, underscoring the need for early recognition and aggressive treatment.
Source →

•
The research identified that women who had not yet delivered their babies were at a much higher risk of death from this lung condition. This finding is crucial for doctors, as it suggests that delivering the baby may be a critical part of the treatment plan to improve the mother’s chances of survival.
Source →

•
A new clinical trial showed that a brain stimulation technique called theta-burst stimulation was effective for treating depression in older adults. This offers a promising, non-drug treatment option for a population that often does not respond well to traditional antidepressants.
Source →

•
The stimulation was applied to both sides of the brain’s prefrontal cortex and compared to a sham (fake) treatment in a randomized trial. The positive results provide strong evidence that this targeted brain stimulation can make a real difference for patients with late-life depression.
Source →

•
A study found that reflective support groups, known as Balint groups, helped emergency medicine doctors manage stress and emotional challenges, leading to improved job satisfaction. This is important because burnout is a major reason why doctors leave this high-pressure specialty.
Source →

•
Doctors who participated in these groups reported feeling better equipped to handle their patients’ emotional needs and believed the program could help retain staff in emergency medicine. This suggests a simple, low-cost intervention could have a significant positive impact on healthcare worker wellbeing and patient care.
Source →

•
Research in Africa is advancing the field of pharmacometrics, which uses math and models to optimize drug dosing and development for local populations. This progress is moving the continent from simply building scientific capacity to creating jobs and influencing local drug regulations.
Source →

•
A major conference highlighted the use of open-source software and focused on solving local health problems, like determining safe drug doses for pregnant women and children. This shift towards self-reliance and tailored solutions is crucial for improving healthcare equity and outcomes across Africa.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article The Legal Frontier of Algorithmic Oversight in Platform Work
Next Article Today’s Neurology Science Briefing | March 24th 2026, 1:00:12 pm
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Sitting isn’t the whole story—how you move may shape metabolic risk

A New Neural Gauge for Autism: The Brain’s Electrical Baseline Holds Clues

Today’s Neurology Science Briefing | March 22nd 2026, 1:00:12 pm

Today’s Neurology Science Briefing | March 13th 2026, 1:00:51 pm

Unlocking ADHD: A New Molecular Target for Learning and Memory

Today’s Public Health Science Briefing | March 16th 2026, 1:00:12 pm

A metabolic signature for predicting gout flare risk

A simpler path to the pleura: rethinking pneumothorax in thoracoscopy

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Gastroenterology
  • Social Sciences
  • Surgery
  • Natural Language Processing
  • Engineering
  • Cell Biology
  • Genetics
  • Immunology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?